Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

The Human Face of Health News: A Multi-Method Analysis of Sourcing Practices in Health-Related News in Belgian Magazines.

De Dobbelaer R, Van Leuven S, Raeymaeckers K.

Health Commun. 2018 May;33(5):611-619. doi: 10.1080/10410236.2017.1287237. Epub 2017 Mar 3.

PMID:
28278607
2.

European Vaccine Initiative: lessons from developing malaria vaccines.

Geels MJ, Imoukhuede EB, Imbault N, van Schooten H, McWade T, Troye-Blomberg M, Dobbelaer R, Craig AG, Leroy O.

Expert Rev Vaccines. 2011 Dec;10(12):1697-708. doi: 10.1586/erv.11.158. Review.

PMID:
22085173
3.

The second Geneva Consensus: Recommendations for novel live TB vaccines.

Walker KB, Brennan MJ, Ho MM, Eskola J, Thiry G, Sadoff J, Dobbelaer R, Grode L, Liu MA, Fruth U, Lambert PH.

Vaccine. 2010 Mar 8;28(11):2259-70. doi: 10.1016/j.vaccine.2009.12.083. Epub 2010 Jan 20. Review.

PMID:
20074686
4.

Guidelines on stability evaluation of vaccines.

Dobbelaer R, Pfleiderer M, Haase M, Griffiths E, Knezevic I, Merkle A, Hongzhang Y, Candrian U, Castillo MA, Wood D, Daviaud J, Dellepiane N, Hernandez CA, Lambert S, Shin J-, Knezevic I, Daviaud J, Fournier-Caruna J, Kopp S, Zhou T, Zaffran M, Bektimirov TA, Cooper G, da Silveira SC, Egan W, Medveczky N, Morris T, Griffiths E, Nunez YH, Horiuchi Y, Jivapaisarnpong T, Krause P, Martin J, Southern J, Tyas Utami AR, Jadhav S, Susanti I, Yamaguchi IK, Duchene M, Laschi A, Schofield TL; World Health Organization.

Biologicals. 2009 Nov;37(6):424-34; discussion 421-3. doi: 10.1016/j.biologicals.2009.08.017. Epub 2009 Oct 29. No abstract available.

PMID:
19875304
5.

Challenges in the evaluation and licensing of new pneumococcal vaccines, 7-8 July 2008, Ottawa, Canada.

Feavers I, Knezevic I, Powell M, Griffiths E; WHO Consultation on Serological Criteria for Evaluation and Licensing of New Pneumococcal Vaccines.

Vaccine. 2009 Jun 8;27(28):3681-8. doi: 10.1016/j.vaccine.2009.03.087. Epub 2009 Apr 17.

PMID:
19442421
6.

WHO Working Group on revision of the Manual of Laboratory Methods for Testing DTP Vaccines-Report of two meetings held on 20-21 July 2006 and 28-30 March 2007, Geneva, Switzerland.

Corbel MJ, Das RG, Lei D, Xing DK, Horiuchi Y, Dobbelaer R; WHO Working Group.

Vaccine. 2008 Apr 7;26(16):1913-21. doi: 10.1016/j.vaccine.2008.02.013. Epub 2008 Feb 21.

PMID:
18336960
7.

WHO working group on standardisation and control of acellular pertussis vaccines--report of a meeting held on 16-17 March 2006, St. Albans, United Kingdom.

Xing DK, Corbel MJ, Dobbelaer R, Knezevic I.

Vaccine. 2007 Apr 12;25(15):2749-57. Epub 2006 Sep 29.

PMID:
17368348
8.

New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development.

Kamath AT, Fruth U, Brennan MJ, Dobbelaer R, Hubrechts P, Ho MM, Mayner RE, Thole J, Walker KB, Liu M, Lambert PH; AERAS Global TB Vaccine Foundation; World Health Organization.

Vaccine. 2005 May 31;23(29):3753-61. Epub 2005 Mar 24. Review.

PMID:
15893612
9.

European union regulatory developments for new vaccine adjuvants and delivery systems.

Sesardic D, Dobbelaer R.

Vaccine. 2004 Jun 23;22(19):2452-6. Review.

PMID:
15193409
10.

Thiomersal in vaccines: a regulatory perspective WHO Consultation, Geneva, 15-16 April 2002.

Knezevic I, Griffiths E, Reigel F, Dobbelaer R.

Vaccine. 2004 May 7;22(15-16):1836-41. No abstract available.

PMID:
15168689
11.
12.

Collaborative study for the establishment of a European Phamacopoeia Biological reference preparation for Bordetella pertussis mouse antiserum for serological potency testing of acellular pertussis vaccines.

Poirier B, Bornstein N, Andre M, Marmonier D, Pares M, Vanhooren G, Rautmann G, Behr-Gross ME, Dobbelaer R, Fuchs F.

Biologicals. 2003 Mar;31(1):25-38.

PMID:
12623057
13.

Collaborative study for the establishment of a European Pharmacopoeia Biological Reference Preparation for pertussis toxin--Part 1.

Dobbelaer R, Daas A, Esposito-Farese ME.

Pharmeuropa Spec Issue Biol. 2001 Aug;2001(1):15-23. No abstract available.

PMID:
11705098
15.

WHO guidelines for the production and control of the acellular pertussis component of monovalent or combined vaccines.

Arciniega JL, Corbel M, Dellepiane N, Dobbelaer R, Griffiths E, Heron I, Ivanoff B, Kreeftenberg H, Mastrantonio P, Meade B, Milstein J, Robertson S, Robinson A, Sato H, Sato Y, Schwanig M, Tiru M.

Biologicals. 1998 Sep;26(3):195-204. No abstract available.

PMID:
10208721
16.

Validation of alternative methods for the potency testing of vaccines.

Hendriksen C, Spieser JM, Akkermans A, Balls M, Bruckner L, Cussler K, Daas A, Descamps J, Dobbelaer R, Fentem J, Halder M, van der Kamp M, Lucken R, Milstien J, Sesardic D, Straughan D, Valadares A.

Altern Lab Anim. 1998 Nov-Dec;26(6):747-61. No abstract available.

PMID:
26042581
17.

The system of mutual recognition of batch release in the EU--implications for combined vaccines.

Dobbelaer R.

Biologicals. 1994 Dec;22(4):377-80. No abstract available.

PMID:
7779364
18.

Sensitivity to avian sensitin of tuberculin reactors in Belgium.

Dobbelaer R.

Dev Biol Stand. 1986;58 ( Pt B):619-29.

PMID:
3111906
20.

Supplemental Content

Loading ...
Support Center